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computed tomography imaging
Paul Cronin, MD, MS,a Gilbert R. Upchurch Jr, MD,b Himanshu J. Patel, MD,c G. Michael Deeb, MD,c
Aine Marie Kelly, MD, MS,a and David M. Williams, MD,d Ann Arbor, Mich; and Charlottesville, Va
Objective: To investigate whether wall growth during aneurysm development spares the aortic wall between the intercostal
or lumbar arteries or, alternatively, is uniform around the circumference.
Methods: Computed tomography scans of 155 patients with aortic aneurysms (40 thoracic, 50 thoracoabdominal, and 65
abdominal) in a single hospital of a large academic institution were retrospectively inspected. Computed tomography
studies of 100 control subjects (40 thoracic and 60 abdominal) were also reviewed. In all 255 patients, the ratio of the arc
length between the origins of the intercostal or lumbar arteries (interbranch arc length) to the remainder of the aortic
residual circumference was calculated. These ratios were compared between all subjects with aneurysms and the controls
at each vertebral body level and between those with thoracic or thoracoabdominal or abdominal aneurysms and controls
at each vertebral body level.
Results: Interbranch arc lengths and residual aortic circumferences were larger in aneurysm patients than in control
subjects, but the differences were statistically signiﬁcant only at T4 and from T8 to L4 (P[ .009 to P < .001) and from
T4 to L4 (P < .001), respectively. The ratio of interbranch arc length to residual circumference in aneurysmal aortas was
signiﬁcantly smaller than that in controls at 12 out of 13 levels from T4 to L4 (P [ .004 to P < .001). There was
a statistically signiﬁcant smaller ratio at 8 out of 9 levels for thoracic aneurysms (P[ .006 to P < .001), 12 out of 13 levels
for thoracoabdominal aneurysms (P[ .008 to P < .001), and 3 out of 4 levels for abdominal aneurysms compared with
controls (P [ .006 to P < .001).
Conclusions: Wall growth in aortic aneurysms is asymmetric, with greater aneurysmal growth in the anterior aorta wall
and relative sparing of the portion of aortic wall between the intercostal or lumbar arteries. The mechanisms effecting this
asymmetric growth have not been fully characterized. (J Vasc Surg 2013;57:390-8.)Considerable literature has accumulated regarding
aortic aneurysms with respect to prevalence, natural
history, epidemiologic factors inﬂuencing growth and
rupture rate, and open and endovascular approaches to
aortic reconstruction.1-4 The estimated prevalence of
abdominal aortic aneurysms (AAAs) is approximately 5%
in men older than 50 years, with rupture rates of 0.3%
for AAAs <4 cm in diameter, 1.5% for those 4.0 to 4.9
cm, and 6.5% for those 5.0 to 5.9 cm, accounting for
1.7% of deaths in men aged 65 to 75 years.2,3 Recently,
a growing literature on biochemical substrates character-
izing the aneurysmal aorta, particularly the study of matrix
metalloproteinase (MMP) activity in aortic wall degenera-
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extracellular matrix, are considered of central importance
in the pathogenesis of AAAs.6,11-15 They also have a role
in thoracic aortic aneurysm pathogenesis.16-18 Several
studies in animal and other models have suggested site-
speciﬁc regional differences in wall biochemistry in the
thoracic and abdominal aorta.16,19,20
While reviewing high-resolution computed tomography
(CT) scans for endograft treatment planning, we noted that
the distance between the intercostal and lumbar arteries
appeared to be relatively spared despite aneurysm enlarge-
ment at the same level (Fig 1). We hypothesized that if
this portion of aortic wall was somehow protected from
aneurysm enlargement, then the ratio of arc length between
intercostal or lumbar artery origins to the residual aortic
circumference should be smaller in patients with aneurysms
than in control subjects. Our preliminary observations in 16
patients with descending thoracic aortic aneurysms sup-
ported this hypothesis and stimulated a pilot study exam-
ining regional variations in MMP activity in surgical
specimens of aortic wall sampled between the intercostal
artery origins and opposite these origins.18 Other regional
variations in aortic wall biology may contribute to aneurysm
development, such as the distribution of vasa vasorum
arising from the intercostal and upper lumbar arteries. The
purpose of this study is to present compelling evidence of
regional variation in aortic wall degeneration and aneurysm
development drawn from a nearly 10-fold larger group of
patients and from aneurysm throughout the aorta, in order
to encourage these and other biochemical investigations into
aortic wall biology.
Fig 1. Intravenous contrast material-enhanced computed tomographic scans. A, Lower thoracic aorta in a control
subject. Note the normal-caliber aorta and the short interbranch arc length (ie, the arc length between the arterial origins
of each paired intercostal artery; black arrow). B, Thoracic aorta in a patient with an aortic aneurysm. Note the increased
diameter of the thoracic aorta but the relatively preserved short interbranch arc length (ie, the arc length between the
arterial origins of each paired intercostal artery; black arrow). C, Abdominal aorta in a patient with an aortic aneurysm at
the level of the celiac axis. Again, note the increased diameter of the abdominal aorta but the relatively preserved short
interbranch arc length (ie, the arc length between the arterial origins of each paired lumbar artery; black arrow).
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Study population. This was a retrospective study.
Institutional review board approval was obtained, and
informed consent was waived. The CT scans of 155 consec-
utive patients (101 males, 54 females; age 35-88 years)
with aortic aneurysms were inspected. Aneurysms were
of the thoracic, thoracoabdominal, and abdominal aorta.
Descending but not ascending aorta or aortic arch aneu-
rysms were included. Thoracoabdominal aneurysms were
a mixture of Crawford I to IV aneurysms. The AAAs were
juxtarenal, pararenal, and infrarenal aneurysms. Of the 155
patients with aortic aneurysms, 40 had thoracic aneurysms
(21 males, 19 females; age 35-85 years), 50 had thoracoab-
dominal aneurysms (30males, 20 females; age 38-83 years),
and 65 had abdominal aneurysms (50males, 15 females; age
38-88 years). The CT scans of 100 consecutive control
subjects (66 males, 34 females; age 41-83 years) were
inspected. Of the 100 control subjects, 40 had thoracic
CT scans (34 males, six females; age 41-64 years), and
60 had abdominal CT scans (32 males, 28 females; age
20-83 years).
Among the aneurysm patients, 70% had a history of
arteriopathy with concomitant cerebrovascular and/or coro-
nary artery and/or renovascular atherosclerotic disease.
Patients with a history of Marfan syndrome, connective
tissue disorder, or vasculitis were excluded from the study.
The thoracic aorta control subjects underwent CT
examinations to assess pulmonary vein anatomy (CT
pulmonary venograms) before radiofrequency ablation
of the pulmonary vein ostia for paroxysmal or persistent
atrial ﬁbrillation. The abdominal aorta control subjects
underwent CT examinations to assess renal vessel
anatomy (CT renal angiograms) before surgical removal
of a kidney for renal donation or treatment of a complex
renal lesion.Imaging protocol. All patients underwent CT scan-
ning performed using a GE LightSpeed 16-row multi-
detector CT scanner (GE Medical Imaging, Milwaukee,
Wisc). Nonionic intravenous contrast material (120 mL of
Omnipaque 300; Nycomed, Inc, Princeton, NJ) was used
for the thoracic aorta, thoracoabdominal aorta, and the
AAA patient scans, and 150 mL of Omnipaque 300 was
used for the control (pulmonary vein CT scans and renal
donor/mass) scans. Intravenous contrast material was
administered at a rate of 4 mL/s using a power injector via
a right antecubital vein. The thoracic or thoracoabdominal
aorta aneurysm scans were initiated using a timing bolus.
The abdominal aorta scans were initiated using SmartPrep
(GE Medical Imaging) with 1.25-mm collimation. The
thoracic or thoracoabdominal aortic aneurysm scans and
the pulmonary vein CT scans had the thoracic portion
performed during a single breath-hold and with ECG
gating, minimizing respiratory motion and cardiac
motion artifact respectively.
Data collection. The aortic circumference was
measured and the thoracic or lumbar vertebral body
number (T4-L4) noted for each measurement. On each
slice containing an intercostal or lumbar artery, the inter-
branch arc length (ie, the arc length between the arterial
origins of each paired artery) was measured, and the verte-
bral body level was noted (Fig 2). When a common trunk
was present, no arc length was measured. The difference
between the aortic circumference and the interbranch arc
length gives the residual aortic circumference. The residual
ratio (ie, the ratio of interbranch arc length to the residual
aortic circumference) was calculated at each level where
an aneurysm was present, from T4 to L4. Aneurysm dila-
tation was deﬁned as an aortic circumference 1.5 times
the upper limit of normal for an aortic circumference at
that level.21,22 Images were reviewed at a GE Advantages
Fig 2. Representation of interbranch arc length and remainder of
the aortic circumference length. On each slice containing an
intercostal or lumbar artery, the arc length between the arterial
origins (interbranch arc length) of each paired artery was measured
(orange arrow) and the vertebral body level noted. The aortic
circumference was measured and the interbranch arc length sub-
tracted, giving the remainder of the aortic circumference length
(blue arrow). The residual ratio (ie, the ratio of interbranch arc
length to the remainder of aortic circumference) was calculated at
each level where an aneurysm was present, from T4 to L4 for each
patient.
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Milwaukee, Wisc) by an experienced cardiovascular
radiologist.
Statistical analysis. Descriptive statistics with mean
and standard deviation of aortic circumference, interbranch
arc length, residual circumference, and residual ratio for
both aneurysm and control subjects were calculated. A
Welch modiﬁed two-sample t-test, which does not
assume the two underlying variances are equal, was per-
formed to assess for differences between aneurysms and
controls. In a secondary analysis, ANOVA was performed
to assess for differences between the controls and patients
with thoracic aneurysms, thoracoabdominal aneurysms,
and abdominal aneurysms. A two-sample t-test was then
performed between controls and thoracic aneurysms,
controls and thoracoabdominal aneurysms, and controls
and abdominal aneurysms. Further analysis using a Welch
modiﬁed two-sample t-test was performed to assess for
differences between the normal portions of aortas in the
aneurysm cohort and the controls.
Linear regression analysis including age and vertebral
body level as potential confounders was also performed
to assess for the correlation of observations at different
vertebral body levels within each subject. P < .05 was
considered statistically signiﬁcant.RESULTS
Total aneurysms vs controls. In total, 1930 aortic
circumference measurements were made, 1270 in aneu-
rysm patients and 660 in control subjects. In aneurysm
patients, 933 circumference measurements met the deﬁni-
tion for aneurysmal dilatation of the aorta at that level. In
these patients, 923 interbranch arc lengths were measured;
10 measurements (L2-L4) could not be made due to the
presence of a common lumbar artery trunk. In control
subjects, 420 measurements were made between T4 and
T12, and 240 measurements were made between L1 and
L4. Lumbar interbranch arc length could not be measured
at 42 levels (L1-L4) due to the presence of a common
trunk. In total, there were 923 aortic interbranch arc
lengths to residual circumference ratios for the aortic
aneurysm patient data set and 618 for the control
subject data set.
Mean aortic circumference, interbranch arc length,
residual aortic circumference, and ratio of arc length to
residual aortic circumference measurements with standard
deviations and ranges for patients with aneurysms and for
controls are given in Table I. Measurements of aortic
circumference, interbranch arc length, residual circumfer-
ence, and the corresponding residual ratio at each vertebral
body level are given in Table II for aneurysm patients and in
Table III for control subjects. The interbranch arc lengths
were larger in aneurysm patients than in control subjects,
but the differences were statistically signiﬁcant only at T4
and from T8 to L4 (Supplementary Table I, online only,
and Fig 3, A). The residual aortic circumference was larger
in aneurysm patients than in control subjects, and the differ-
ences were statistically signiﬁcant at each vertebral body
level from T4 to L4 (Supplementary Table I, online only,
and Fig 3, B). Residual ratios were reduced in aneurysm
patients compared with normal subjects, and the differences
were statistically signiﬁcant at all but the L4 level
(Supplementary Table I, online only, and Fig 3, C).
Linear regression analysis of age and vertebral body
level as potential confounders showed that although aortic
circumference increases with age (expected increment
during 1 year is 0.76 mm, based on our data), the increase
of aortic branch arc length with age was not signiﬁcant
(P ¼ .24). Although the ratio decreases with age, this
was less signiﬁcant compared with the differences between
aneurysm patients and normal subjects (P < .001). Simi-
larly, although the aortic circumference and the aortic
branch arc length increase in the caudocranial direction,
these increases were less signiﬁcant compared with the
differences between aneurysm patients and normal subjects
(P < .001). Therefore, age and vertebral body level are not
signiﬁcant confounders.
Subset analysis. Comparison between controls and
patients with thoracic aneurysms, thoracoabdominal aneu-
rysms, and abdominal aneurysms was performed. Mean
aortic circumference, interbranch arc length, residual aortic
circumference, and ratio of arc length to residual thoracic
aortic circumferencemeasurementswith standard deviations
Table I. Mean, standard deviation (SD), and range of aortic circumference, interbranch arc length, residual aortic
circumference, and ratio of arc length to residual aortic circumference for patients with aneurysms and for controls at all
vertebral body levels
All levels
No. of
measurements
Circumference,
mean (SD), mm
Interbranch arc length,
mean (SD), mm
Residual circumference,
mean (SD), mm
Residual ratio,
mean (SD)
Total aneurysm 923 141.7 (32.8)
[80.7-282.9]
14.3 (6.6)
[3.0-40.1]
127.4 (31.6)
[73.0-271.8]
0.12 (0.06)
[0.03-0.44]
Control 618 67.2 (15.2)
[36.1-119.6]
11.2 (5.6)
[3.0-31.0]
57.3 (12.4)
[32.8-93.7]
0.20 (0.10)
[0.04-0.71]
Thoracic aneurysm 265 150.0 (27.3)
[113.4-241.8]
16.0 (7.0)
[4.0-40.1]
127.4 (31.6)
[73.0-271.8]
0.12 (0.06)
[0.03-0.44]
Control 420 74.9 (11.4)
[50.6-119.6]
13.0 (5.7)
[3.0-31.0]
61.9 (10.4)
[38.1-93.7]
0.22 (0.11)
[0.04-0.71]
Thoracoabdominal aneurysm 480 139.7 (32.4)
[80.7-282.9]
14.9 (6.4)
[3.0-40.1]
125.7 (31.0)
[73.0-271.8]
0.12 (0.06)
[0.03-0.38]
Control 618 67.2 (15.2)
[36.1-119.6]
11.2 (5.6)
[3.0-31.0]
57.3 (12.4)
[32.8-93.7]
0.20 (0.10)
[0.04-0.7]
Abdominal aneurysm 178 134.9 (38.2)
[80.9-282.9]
12.7 (6.0)
[3.1-32.3]
122.2 (37.8)
[77.7-271.8]
0.11 (0.06)
[0.0-0.28]
Control 198 53.9 (11.0)
[36.1-94.2]
7.4 (2.5)
[3.0-17.0]
47.3 (10.2)
[32.8-84.2]
0.16 (0.06)
[0.06-0.47]
Ranges are given in square brackets.
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in Table I. As expected, measurements of the residual
aortic circumferencewere larger in aneurysmpatients than in
control subjects, and the differences were statistically
signiﬁcant at each vertebral body level from T4 to L4.
Interbranch arc lengths were also larger in aneurysm patients
than in control subjects, but the differences were statistically
signiﬁcant only at T4 and from T9 to L4 (Supplementary
Table I, online only). Residual ratios were reduced in
aneurysm patients compared with normal subjects, and the
differences were statistically signiﬁcant at all 13 levels
(Supplementary Table I, online only).
Thoracic aneurysms vs controls. In total, 780
thoracic aortic circumference measurements were made,
360 in aneurysm patients and 420 in control subjects. In
the thoracic aneurysm patients, 265 circumference
measurements met the deﬁnition for thoracic aneurysmal
dilatation of the aorta at that level. Measurements for
patients with thoracic aneurysms and for thoracic controls
are given in Table I. Measurements of aortic circumfer-
ence, interbranch length, and the corresponding residual
ratio at each vertebral body level for thoracic aneurysm
patients are given in Supplementary Table II, online only.
The interbranch arc lengths were larger in aneurysm
patients than in control subjects, but the differences were
statistically signiﬁcant only at T4 and from T8 to T12
(Supplementary Table II, online only, and Fig 4). The
residual aortic circumferences were larger in aneurysm
patients than in control subjects, and the differences were
statistically signiﬁcant at each vertebral body level from T4
to T12. Residual ratios were reduced in thoracic aneurysm
patients compared with normal thoracic subjects, and the
differences were statistically signiﬁcant at all but the T11
level (Supplementary Table II, online only, and Fig 4).Thoracoabdominal aneurysms vs controls. In total,
1310 thoracoabdominal aortic circumference measure-
ments were made, 650 in aneurysm patients and 660 in
control subjects. In thoracoabdominal aneurysm patients,
487 circumference measurements met the deﬁnition for
aneurysmal dilatation of the aorta at that level. In total,
480 interbranch arc lengths were measured; at seven levels
(L3-L4), the measurements could not be made due to the
presence of a common lumbar artery trunk. In control
subjects, 420 measurements were made between T4 and
T12, and 240 measurements were made between L1 and
L4. For L1 to L4, 42 lumbar interbranch arc lengths could
not be measured due to the presence of a common trunk,
giving a total of 198 measurements for the control subject
data set. Measurements for patients with thoracoabdominal
aneurysms and for thoracic and abdominal controls are
given in Table I. Measurements of aortic circumference,
interbranch length, and the corresponding residual ratio at
each vertebral body level for thoracoabdominal aneurysm
patients are given in Supplementary Table III, online only.
The interbranch arc lengths were larger in aneurysm
patients than in control subjects, but the differences were
statistically signiﬁcant only at T4 and from T8 to L4
(Supplementary Table III, online only, and Fig 5). The
residual aortic circumferences were larger in aneurysm
patients than in control subjects, and the differences were
statistically signiﬁcant at each vertebral body level from
T4 to L4. Residual ratios were reduced in aneurysm
patients compared with control subjects, and the differ-
ences were statistically signiﬁcant at all but the L4 level
(Supplementary Table III, online only, and Fig 5).
Abdominal aneurysms vs controls. In total, 500
abdominal aortic circumference measurements were
made, 260 in aneurysm patients and 240 in control
Table II. Number of measurements, average aortic circumference, average interbranch arc length, average residual aortic
circumference, and average interbranch arc length to residual aortic circumference residual ratio for aneurysm patients at
each vertebral level
Total aneurysm
No. of
measurements
Circumference,
mean (SD), mm
Interbranch arc length,
mean (SD), mm
Residual circumference,
mean (SD), mm
Residual ratio,
mean (SD)
T4 19 137.5 (19.7) 15.1 (3.2) 122.4 (19.4) 0.13 (0.04)
T5 46 149.9 (28.6) 20.6 (10.5) 129.3 (26.3) 0.17 (0.10)
T6 56 155.1 (26.4) 17.2 (7.0) 137.9 (25.4) 0.13 (0.05)
T7 75 153.7 (29.0) 15.0 (5.8) 138.7 (30.7) 0.12 (0.06)
T8 83 152.4 (29.0) 13.1 (5.6) 139.3 (27.4) 0.10 (0.04)
T9 84 149.0 (23.4) 14.6 (4.8) 148.3 (22.1) 0.11 (0.04)
T10 85 152.6 (33.1) 16.0 (7.3) 136.7 (29.9) 0.12 (0.05)
T11 74 140.1 (26.8) 14.7 (6.0) 125.4 (27.5) 0.12 (0.06)
T12 75 135.8 (26.3) 15.5 (6.6) 120.3 (25.2) 0.13 (0.06)
L1 79 135.6 (36.0) 13.2 (5.5) 122.4 (36.3) 0.11 (0.06)
L2 101 (1) 124.1 (34.6) 11.4 (4.9) 112.1 (32.7) 0.11 (0.05)
L3 92 (3) 129.8 (35.7) 12.1 (6.6) 117.8 (32.8) 0.11 (0.06)
L4 64 (6) 134.3 (42.3) 11.9 (6.3) 121.2 (41.1) 0.11 (0.06)
SD, Standard deviation.
Numbers in parentheses in the number of measurements column indicate the number of interbranch arc lengths, residual aortic circumferences, and inter-
branch arc length to residual aortic circumference residual ratios that could not be calculated due to the presence of a common trunk.
Table III. Normal aortic diameter, normal aortic circumference, number of measurements, average aortic circumference,
average interbranch arc length, average residual aortic circumference, and average interbranch arc length to residual aortic
circumference residual ratio for control subjects at each vertebral level
Control
Normal diameter,a
mean (SD), mm
Normal
circumference,a
mean (SD), mm
No. of
measurements
Circumference,
mean (SD), mm
Interbranch
arc length,
mean (SD), mm
Residual
circumference,b
mean (SD), mm
Residual ratio,c
mean (SD)
T4 26 (4) 82 (13) 32 81.4 (12.0) 21.0 (6.4) 60.4 (11.7) 0.36 (0.1)
T5 26 (4) 82 (13) 40 78.7 (9.1) 19.5 (6.0) 59.2 (9.4) 0.34 (0.1)
T6 26 (4) 82 (13) 40 77.3 (8.8) 16.7 (6.0) 60.7 (8.8) 0.28 (0.1)
T7 25 (4) 79 (13) 40 76.5 (8.0) 13.1 (4.5) 63.4 (7.3) 0.21 (0.1)
T8 25 (4) 79 (13) 44 78.0 (10.1) 10.7 (3.2) 67.3 (8.1) 0.16 (0.1)
T9 25 (4) 79 (13) 44 78.9 (10.3) 10.3 (3.6) 68.6 (9.3) 0.15 (0.1)
T10 24 (3.5) 75 (11) 48 76.8 (11.8) 11.0 (3.9) 65.8 (10.8) 0.17 (0.1)
T11 24 (3.5) 75 (11) 64 69.5 (12.0) 9.5 (3.1) 60.0 (10.3) 0.16 (0.1)
T12 24 (3.5) 75 (11) 68 66.5 (10.7) 11.3 (2.6) 55.2 (9.5) 0.21 (0.1)
L1 21 (3) 66 (9) 60 (2) 60.2 (13.3) 8.1 (1.3) 51.2 (12.4) 0.17 (0.1)
L2 20 (3) 63 (9) 60 (10) 53.9 (10.3) 7.0 (2.2) 47.1 (10.3) 0.15 (0.05)
L3 19 (3) 60 (9) 60 (8) 51.0 (9.2) 7.2 (2.1) 44.6 (7.4) 0.16 (0.1)
L4 18 (3) 57 (9) 60 (22) 50.3 (8.1) 6.8 (4.2) 44.9 (8.1) 0.15 (0.1)
SD, Standard deviation.
Numbers in parentheses in the number of measurements column indicate the number of interbranch arc lengths, residual aortic circumferences, and inter-
branch arc length to residual aortic circumference residual ratios that could not be calculated due to the presence of a common trunk.
aData on normal diameter and normal circumference have been previously published.21,22
bResidual circumference is circumference minus interbranch arc length.
cResidual ratio is ratio of interbranch arc length to residual circumference.
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ence measurements met the deﬁnition for aneurysmal
dilatation of the aorta at that level. In total, 178 inter-
branch arc lengths were measured; at three levels (L2-
L4), the measurements could not be made due to the
presence of a common lumbar artery trunk. In control
subjects, 240 measurements were made between L1 and
L4. Lumbar interbranch arc length could not be
measured at 42 levels (L1-L4) due to the presence ofa common trunk, giving a total of 198 measurements
for the control subject data set. Measurements for patients
with abdominal aneurysms and for abdominal controls are
given in Table I. Measurements of aortic circumference,
interbranch length, and the corresponding residual ratio
at each vertebral body level for abdominal aneurysm
patients are given in Supplementary Table IV, online only.
Interbranch arc lengths were larger in aneurysm patients
than in control subjects, and the differences were
Fig 3. A, Arc length between posterior paired branch vessels of
the total aneurysm patients compared with that of control subjects,
at each vertebral body level from T4 to L4. Arc length between
JOURNAL OF VASCULAR SURGERY
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(Supplementary Table IV, online only, and Fig 6).
Residual aortic circumference was larger in aneurysm
patients than in control subjects, and the differences were
statistically signiﬁcant at each vertebral body level from T4
to L4. Residual ratios were reduced in aneurysm patients
compared with normal subjects, and the differences were
statistically signiﬁcant at all but the L4 level
(Supplementary Table IV, online only, and Fig 6).
Nonaneurysmal segments in aneurysm cohort vs
controls. In aneurysm patients, 171 circumference
measurements met the deﬁnition for normal-caliber aorta
at that level. In total, 167 interbranch arc lengths were
measured; four measurements (L2-L4) could not be
made due to the presence of a common lumbar artery
trunk. These measurements were compared with 618
measurements in control subjects. Mean aortic circumfer-
ence, interbranch arc length, residual aortic circumference,
and ratio of arc length to residual aortic circumference
measurements for nonaneurysmal segments in the aneu-
rysm cohort and for controls are given in Supplementary
Table V, online only. There was no statistical difference
between the nonaneurysmal segments of aneurysm patients
and those of control patients at 11 levels. At two levels
(T12 and L2), there were statistical differences between the
normal segments of aneurysm patients and control
patients; however, the numbers of measurements are small.
DISCUSSION
This study was undertaken to establish whether differ-
ential growth existed in the anterior and posterior wall of
aortic aneurysms. A previous study comparing CT scans
from 16 controls and 16 patients with descending aortic
aneurysms showed that arc distance (ie, the length of the
curve between the intercostals) made up a signiﬁcantly
smaller proportion of the entire aortic circumference,18
suggesting that most aneurysmal growth occurs in the
anterior thoracic aortic wall. The present study compares
155 aneurysm patients with 100 controls and assesses
descending thoracic aorta aneurysms, Crawford I to IV
thoracoabdominal aneurysms, and juxtarenal, pararenal,
and infrarenal AAAs.posterior paired branch vessels (interbranch arc length) of aneu-
rysmal aortas is larger at each vertebral level compared with
controls (P < .05). The differences were statistically signiﬁcant
only at T4 and from T8 to L4. B, Residual aortic circumference
lengths of total aneurysm patients compared with control subjects,
at each vertebral body level from T4 to L4. The circumference of
the aneurysmal aortas is larger compared with that of controls at
each vertebral level, and the differences were statistically signiﬁcant
at all vertebral levels. C, Comparison between interbranch arc
length to residual aortic circumference ratio of total aneurysm
patients compared with that of control subjects, at each vertebral
body level from T4 to L4. The aortic posterior branch arc length
to residual aortic circumference ratio is reduced compared with
that of controls at each vertebral level and was signiﬁcantly
different (P < .05) at all vertebral body levels from T4 to L4,
except at the L4 levels.
Fig 4. Comparison of interbranch arc length to residual aortic
circumference ratio of thoracic aneurysm patients compared with
that of control subjects, at each vertebral body level from T4 to
T12. The aortic posterior branch arc length to residual aortic
circumference ratio is reduced compared with that of controls at
each vertebral level, and the differences were statistically signiﬁcant
(P < .05) at all vertebral body levels from T4 to T12, except at the
T11 level.
Fig 5. Comparison of interbranch arc length to residual aortic
circumference ratio of thoracicoabdominal aneurysm patients
compared with that of control subjects, at each vertebral body level
from T4 to L4. The aortic posterior branch arc length to residual
aortic circumference ratio is reduced compared with that of
controls at each vertebral level, and the differences were statistically
signiﬁcant (P < .05) at all vertebral body levels from T4 to L4,
except at the L4 levels.
Fig 6. Comparison of interbranch arc length to residual aortic
circumference ratio of abdominal aneurysm patients compared with
that of control subjects, at each vertebral body level from L1 to L4.
The aortic posterior branch arc length to residual aortic circumfer-
ence ratio is reduced compared with that of controls at each verte-
bral level, and the differences were statistically signiﬁcant (P < .05)
at all vertebral body levels from L1 to L4, except at the L4 levels.
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increase in the distance between the paired posterior aorta
branch vessels with aneurysm formation, there is differen-
tial increased enlargement of the aorta wall anterior tothe paired branch vessels compared with the aorta wall
between the intercostal or lumbar artery origins. Our
results also show that there is differential growth in
descending thoracic, thoracoabdominal, and abdominal
aneurysms, with the region between the intercostal and
lumbar arteries relatively protected. Possible mechanisms
include protection from ischemia provided by vasa vasorum
arising from branch arteries, or regional variation in
enzymes degrading, protecting, or repairing elastic tissue.
Because the intercostal arteries are a principal supply of
the vasa vasorum, the wall close to these vessel origins
may be better oxygenated and better nourished than the
wall remote from them. We do not believe that a “tethering
effect” by intercostal and lumbar arteries has a prominent
protective effect on the aortic wall between them because
these vessels are capable of considerable longitudinal
growth or extension when large infrarenal aneurysms bulge
anteriorly (Fig 7). Furthermore, the intercostal and lumbar
arteries do not seem to tether the false lumen of a chronic
dissection and prevent or mitigate aneurysmal growth
(Fig 8). Our ﬁndings raise the question of whether other
portions of aortic wall, such as that bearing the left subcla-
vian origin, might be similarly protected. We did not
compile data on these segments of the aortic wall. In
fact, there are practical difﬁculties in making these measure-
ments. These branch artery diameters are perhaps one-half
or one-third of the distance between the intercostal
arteries, and the transition between aorta and branch artery
is more gradual, so measurement inaccuracies are apt to be
more signiﬁcant than observations based on intercostal and
lumbar arteries.
Fig 8. A 14-day-old type B dissection. A, Paired intercostal
arteries. B, The ﬂap is reﬂected along the line of dissection. There
is migration of the intercostal artery origins from holes on the ﬂap,
which shows acute expansion of the false lumen. The second zone
of expansion is marked by the black arrows. C, Magniﬁed portion
of the image outlined by the black box in B. Separation of true
lumen (black arrows) and false lumen (arrowheads) intercostal
artery origins is shown in an unﬁxed specimen.
Fig 7. Lumbar arteries in a patient with chronic dissection. The
intercostal/lumbar arteries do not seem to tether the false lumen
of a chronic dissection and prevent or mitigate aneurysmal growth.
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aneurysms span a wide range of diameters, from 27 to 91
mm. For all aneurysm sizes, asymmetric growth is statisti-
cally signiﬁcant. A second strength is that our division of
the aortic circumference into the intercostal/interlumbar
arc and the residual circumference is conservative with
respect to our hypothesis that this portion of the aortic
wall is protected in some way. The same mechanism may
protect the wall in some radius of inﬂuence, which extends
longitudinally as well as transversely into what we have
called the residual circumference. If the circumference of
the aorta is c and the distance between the segmental
arteries is 2d, our residual ratio is 2d/(c e 2d). Assuming
a protective inﬂuence of radius d around each segmental
artery, the residual ratio is 4d/(c e 4d). Residual ratios
using the 4d/(c e 4d) calculation were also reduced in
thoracoabdominal aneurysm patients compared with
control subjects, and the differences were statistically signif-
icant at all but the L4 level, similar to the 2d/(c e 2d)
method of calculation (Supplementary Table VI, online
only).
Potential selection bias in this study was minimized by
using a consecutive cohort of patients and controls. This
study was designed only to establish the presence of an
outcome (asymmetric formation of aortic aneurysms).
Therefore, misclassiﬁcation or information bias is not an
issue. Implicit in our study is the assumption that at
some point in time, the patients’ aortas were normal in
diameter and then, unobserved, grew to a size deﬁned as
aneurysmal. Further study could examine serial CTs in
individual patients to determine differential growth more
precisely. Until such studies can be performed, the compar-
ison of aneurysmal aortas to controls is a reasonable substi-
tute for the comparison of aneurysmal aortas to their
undocumented baseline normal status. The comparison
of controls to normal segments in the aneurysm cohort is
instructive. At most levels, there was no signiﬁcant differ-
ence, suggesting that aneurysm wall growth may have
started at a baseline close to that of the normal population.However, there is evidence that abnormal and regional
variation in wall biology may be present even without overt
aneurysm development.20 A related observational study
would compare the aortic wall shrinkage rate between
the segment between intercostal and lumbar arteries and
the residual circumference of the aneurysm sac after endog-
raft treatment, although thrombosis of lumbar artery
origins may complicate measurement of interbranch arc
lengths.
Our ﬁndings establish conclusively that there is asym-
metric growth in a wide variety of aortic aneurysms and
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aortic wall biology to explain the regional variation in
aneurysmal wall degeneration. Although our pilot study
has shown signiﬁcant differential expression of MMP-9
and MMP-2 in the anterior and posterior walls of aortic
aneurysms, it would be fruitful to relate this variable
expression to proximity, size, and density of the vasa vaso-
rum, or to some other geographic modulator of tissue
perfusion or wall stress. Identifying the protective mecha-
nism of the posterior aortic wall would likely have impor-
tant implications for the treatment and management of
aortic aneurysms in the future. Further research is required.
Therapies aimed at slowing aneurysm growth might
beneﬁt from targeting the area of the aortic wall more
prone to accelerated growth. Knowledge of accelerated
and differential growth of the aorta might also be impor-
tant for developing more physiologically directed endog-
rafts (eg, more aggressive ﬁxation posteriorly, stronger
materials anteriorly).
CONCLUSIONS
Aneurysmal aortas have differential enlargement of the
aortic wall, with signiﬁcantly greater enlargement of the
aortic wall anterior/opposite to the paired posterior branch
vessels compared with the aortic wall between the paired
posterior branch vessels. This ﬁnding may indicate that
different mechanisms are responsible for aneurysm growth
or that there is a protective mechanism within the aortic
wall between the paired posterior branch vessels, which
requires further investigation.
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Supplementary Table I (online only). t-test statistics and P values for interbranch arc length, residual aortic
circumference, and interbranch arc length to residual aortic circumference residual ratio for total aneurysm patients vs
control subjects at each vertebral level, and F-test statistics and P values for residual aortic circumference, interbranch arc
length, and interbranch arc length to residual aortic circumference residual ratio for thoracic or thoracoabdominal or
abdominal aortic aneurysm patients vs control subjects at each vertebral level
Control vs total aortic aneurysm, t-statistic
(P value)
Control vs thoracic vs thoracoabdominal vs abdominal aortic
aneurysm, F-statistic (P value)
Interbranch arc
length
Residual
circumference Residual ratio
Interbranch arc
length
Residual
circumference Residual ratio
3.35 (.003) 11.67 (<.001) 6.27 (<.001) T4 6.11 (.006) 47.91 (<.001) 22.30 (<.001)
0.306 (.761) 15.90 (<.001) 5.72 (<.001) T5 0.20 (.820) 57.86 (<.001) 19.30 (<.001)
0.07 (.945) 19.71 (<.001) 6.10 (<.001) T6 0.15 (.860) 84.88 (<.001) 33.84 (<.001)
1.57 (.125) 19.31 (<.001) 5.14 (<.001) T7 0.94 (.400) 68.51 (<.001) 16.30 (<.001)
2.67 (.009) 20.33 (<.001) 5.59 (<.001) T8 2.01 (.140) 69.44 (<.001) 17.24 (<.001)
4.69 (.001) 20.62 (<.001) 3.13 (.004) T9 7.76 (.001) 96.50 (<.001) 8.12 (<.001)
4.44 (.001) 18.06 (<.001) 3.61 (.001) T10 5.37 (.006) 59.92 (<.001) 8.03 (<.001)
5.77 (.001) 17.82 (<.001) 3.26 (.002) T11 12.26 (.001) 100.50 (<.001) 5.38 (.006)
4.77 (.001) 19.53 (<.001) 6.57 (<.001) T12 7.34 (.001) 108.10 (<.001) 18.83 (<.001)
7.70 (.001) 15.26 (<.001) 5.02 (<.001) L1 13.98 (.001) 64.11 (<.001) 10.48 (<.001)
6.62 (<.001) 16.43 (<.001) 4.06 (<.001) L2 14.06 (<.001) 61.57 (<.001) 9.62 (<.001)
6.20 (<.001) 18.77 (<.001) 4.64 (<.001) L3 7.36 (.001) 71.80 (<.001) 9.23 (<.001)
3.93 (<.001) 12.95 (<.001) 1.82 (.085) L4 5.21 (.008) 64.23 (<.001) 3.41 (.039)
Supplementary Table II (online only). Number of measurements, average aortic circumference, average interbranch
arc length, average residual aortic circumference, and average interbranch arc length to residual aortic circumference
residual ratio for thoracic aneurysm patients at each vertebral level, and t-test statistics and P values for interbranch arc
length, residual aortic circumference, and interbranch arc length to residual aortic circumference residual ratio for thoracic
aneurysm patients vs control subjects at each vertebral level
Thoracic aneurysm
Control vs thoracic aortic aneurysm, t-statistic
(P value)
No. of
measurements
Circumference,
mean (SD), mm
Interbranch
arc length,
mean (SD), mm
Residual
circumference,
mean (SD), mm
Residual ratio,
mean (SD)
Interbranch
arc length
Residual
circumference
Residual
ratio
10 137.8 (18.6) 14.8 (3.4) 123.0 (18.0) 0.12 (0.04) T4 3.23 (.004) 9.81 (<.001) 6.25 (<.001)
23 150.4 (28.6) 21.2 (10.8) 129.1 (27.1) 0.17 (0.11) T5 0.67 (.508) 11.61 (<.001) 4.81 (<.001)
24 160.2 (25.2) 17.7 (7.2) 142.5 (25.0) 0.13 (0.06) T6 0.50 (.618) 14.98 (<.001) 5.76 (<.001)
36 155.2 (28.8) 15.1 (5.7) 140.1 (30.7) 0.12 (0.06) T7 1.44 (.156) 14.27 (<.001) 4.75 (<.001)
39 154.0 (29.5) 13.4 (5.8) 140.6 (28.1) 0.10 (0.04) T8 2.39 (.020) 15.16 (<.001) 4.93 (<.001)
38 153.1 (22.7) 14.8 (5.2) 138.3 (21.1) 0.11 (0.04) T9 3.98 (.001) 17.43 (<.001) 3.16 (.004)
38 152.0 (33.4) 16.5 (7.7) 135.5 (30.2) 0.12 (0.06) T10 3.77 (.001) 13.12 (<.001) 2.22 (.006)
30 140.5 (20.2) 16.0 (6.3) 124.5 (22.4) 0.14 (0.07) T11 5.11 (.001) 14.54 (<.001) 1.51 (.137)
27 136.2 (22.1) 16.6 (6.7) 119.5 (22.1) 0.14 (0.07) T12 3.93 (.001) 14.18 (<.001) 4.08 (<.001)
SD, Standard deviation.
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Supplementary Table III (online only). Number of measurements, average aortic circumference, average interbranch
arc length, average residual aortic circumference, and interbranch arc length to residual aortic circumference residual
ratio for thoracoabdominal aneurysm patients at each vertebral level, and t-test statistics and P values for interbranch arc
length, residual aortic circumference, and interbranch arc length to residual aortic circumference residual ratio for
thoracoabdominal aneurysm patients vs control subjects at each vertebral level
Thoracoabdominal aneurysm
Control vs thoracoabdominal
aortic aneurysm, t-statistic (P value)
No. of
measurements
Circumference,
mean (SD), mm
Interbranch
arc length,
mean (SD), mm
Residual
circumference,
mean (SD), mm
Residual
ratio,
mean (SD)
Interbranch
arc
length
Residual
circumference
Residual
ratio
9 137.2 (22.1) 15.5 (3.2) 121.7 (21.9) 0.13 (0.04) T4 2.89 (.009) 7.81 (<.001) 5.94 (<.001)
23 149.4 (29.4) 20.0 (10.4) 129.4 (26.1) 0.16 (0.09) T5 0.19 (.851) 12.04 (<.001) 5.55 (<.001)
32 151.3 (27.0) 16.8 (7.0) 134.5 (25.5) 0.13 (0.05) T6 0.07 (.946) 15.00 (<.001) 5.97 (<.001)
39 152.3 (29.5) 14.9 (5.9) 137.5 (31.0) 0.12 (0.06) T7 1.31 (.197) 14.18 (<.001) 4.80 (<.001)
44 151.0 (28.9) 12.9 (5.5) 138.2 (27.3) 0.10 (0.04) T8 2.03 (.047) 15.69 (<.001) 5.32 (<.001)
46 145.7 (23.6) 14.5 (4.6) 131.2 (22.7) 0.11 (0.04) T9 4.13 (.001) 15.86 (<.001) 2.85 (.008)
47 153.1 (33.2) 15.5 (7.1) 137.6 (30.3) 0.12 (0.05) T10 3.48 (.001) 14.73 (<.001) 3.69 (<.001)
44 139.7 (30.8) 13.8 (5.8) 126.0 (30.8) 0.11 (0.06) T11 4.11 (.001) 13.25 (<.001) 3.72 (<.001)
48 135.6 (28.7) 14.8 (6.6) 120.8 (27.0) 0.13 (0.06) T12 3.43 (.001) 15.50 (<.001) 6.51 (<.001)
44 130.4 (36.0) 12.4 (5.2) 118.0 (35.9) 0.11 (0.06) L1 5.14 (.001) 11.35 (<.001) 4.67 (<.001)
49 119.4 (32.0) 10.1 (4.3) 109.3 (31.5) 0.10 (0.05) L2 4.11 (<.001) 12.56 (<.001) 4.63 (<.001)
36 (2) 125.4 (32.5) 11.5 (5.9) 113.9 (31.8) 0.11 (0.06) L3 3.97 (.001) 12.27 (<.001) 4.01 (.001)
26 (5) 125.5 (36.6) 12.1 (6.2) 108.0 (35.1) 0.12 (0.05) L4 3.16 (.003) 7.99 (<.001) 1.36 (.187)
SD, Standard deviation.
Numbers in parentheses in the number of measurements column indicate the number of interbranch arc lengths, residual aortic circumferences, and inter-
branch arc length to residual aortic circumference residual ratios that could not be calculated due to the presence of a common trunk.
Supplementary Table IV (online only). Number of measurements, average aortic circumference, average interbranch
arc length, average residual aortic circumference, and interbranch arc length to residual aortic circumference residual ratio
for abdominal aneurysm patients at each vertebral level, and t-test statistics and P values for residual aortic circumference,
interbranch arc length, and interbranch arc length to residual aortic circumference residual ratio for aneurysm patients vs
control subjects at each vertebral level
Abdominal aneurysm
Control vs abdominal aortic aneurysm,
t-statistic (P value)
No. of
measurements
Circumference,
mean (SD), mm
Interbranch
arc length,
mean (SD), mm
Residual
circumference,
mean (SD), mm
Residual ratio,
mean (SD)
Interbranch
arc length
Residual
circumference Residual ratio
35 142.1 (35.8) 14.2 (5.6) 127.9 (36.0) 0.12 (0.10) L1 6.26 (.001) 11.78 (<.001) 3.87 (<.001)
52 (1) 128.5 (36.6) 12.6 (5.2) 115.9 (36.8) 0.12 (0.10) L2 6.59 (<.001) 12.50 (<.001) 2.89 (.006)
56 (1) 132.6 (37.6) 12.5 (6.8) 120.1 (35.7) 0.11 (0.10) L3 5.31 (.001) 15.13 (<.001) 4.15 (<.001)
38 (1) 140.3 (43.2) 11.8 (6.2) 128.5 (43.0) 0.10 (0.10) L4 3.54 (.001) 11.53 (<.001) 1.98 (.062)
SD, Standard deviation.
Numbers in parenthesis in the number of measurements column indicate the number of interbranch arc lengths, residual aortic circumferences, and inter-
branch arc length to residual aortic circumference residual ratios that could not be calculated due to the presence of a common trunk.
JOURNAL OF VASCULAR SURGERY
398.e2 Cronin et al February 2013
Supplementary Table V (online only). Number of measurements, average aortic circumference, average interbranch
arc length, average residual aortic circumference, and interbranch arc length to residual aortic circumference residual ratio
in normal aortic segments of aneurysm cohort at each vertebral level, and P values for the residual ratio in normal aortic
segments of aneurysm cohort vs control subjects at each vertebral level
Normal aorta segments in aneurysm cohort
Control vs normal aorta
in aneurysm cohort
No. of
measurements
Circumference,
mean, mm
Interbranch
arc length,
mean, mm
Residual
circumference,
mean, mm
Residual ratio,
mean Residual ratio (P value)
6 79.8 20.6 59.2 0.35 T4 (.25)
9 80.3 18.4 61.9 0.30 T5 (.06)
9 79.3 15.8 63.5 0.27 T6 (.11)
8 78.3 13.9 64.4 0.22 T7 (.15)
7 79.8 10.3 66.4 0.16 T8 (.16)
6 70.9 11.4 59.5 0.18 T9 (.30)
12 72.2 11.3 60.9 0.18 T10 (.50)
12 72.5 10.1 62.4 0.16 T11 (.09)
24 71.9 9.9 62.0 0.16 T12 (<.002)
18 63.7 8.2 55.5 0.15 L1 (.06)
16 (2) 61.3 7.8 53.5 0.15 L2 (<.002)
23 (1) 59.1 8.5 50.6 0.17 L3 (.17)
17 (1) 50.6 6.7 43.9 0.15 L4 (.23)
Numbers in parentheses in the number of measurements column indicate the number of interbranch arc length to residual aortic circumference residual ratios
that could not be calculated due to the presence of a common trunk.
Supplementary Table VI (online only). t-test statistics
and P values for residual ratio for thoracoabdominal
aneurysm patients vs control subjects at each vertebral
level using the 4d/(c e 4d) calculation
No. of measurements
Residual ratio 4d/(c e 4d),
t-statistic (P value)
9 T4 2.79 (.0103)
23 T5 5.33 (<.001)
32 T6 6.95 (<.001)
39 T7 4.91 (<.001)
44 T8 5.39 (<.001)
46 T9 3.43 (.001)
47 T10 3.91 (<.001)
44 T11 3.20 (.002)
48 T12 5.87 (<.001)
44 L1 4.30 (<.001)
49 L2 4.65 (<.001)
36 (2) L3 3.75 (<.001)
26 (5) L4 1.47 (.15)
Numbers in parentheses in the number of measurements column indicate
the number of interbranch arc length to residual aortic circumference
residual ratios that could not be calculated due to the presence of a common
trunk.
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